Anti-CDKN2A/p19ARF antibody
4
(15 Reviews)
|
(234 Publications)
Anti-CDKN2A/p19ARF antibody (ab80) is a rabbit polyclonal antibody detecting CDKN2A/p19ARF in Western Blot, IHC-P, IHC-Fr, ICC/IF, ELISA. Suitable for Mouse.
- Over 220 publications
- Trusted since 2002
View Alternative Names
Tumor suppressor ARF, Alternative reading frame, Cyclin-dependent kinase inhibitor 2A, p19ARF, ARF, Cdkn2a
- WB
Collaborator
Western blot - Anti-CDKN2A/p19ARF antibody (AB80)
Western blot of primary Mouse Embryo Fibroplasts (MEFs) using ab80 at 1 μg/ml. (30 μg of protein from total cell extracts per lane.)
All lanes:
Western blot - Anti-CDKN2A/p19ARF antibody (ab80) at 1 µg/mL
Lanes 1 - 2:
mouse embryonic fibroblast total cell extract at 30 µg
Lane 3:
mouse embryonic fibroblast total cell extract, with the p19ARF gene knocked out as a negative control at 30 µg
Predicted band size: 18 kDa
false
This image is courtesy of Charles Sherr
- ICC
Collaborator
Immunocytochemistry - Anti-CDKN2A/p19ARF antibody (AB80)
ab80 antibody was tested on NIH 3T3 cells (which have a deletion of the p19ARF gene) as a negative control (-) and NIH 3T3 cells engineered to express HA-tagged p19ARF as a positive control (+).
Cells grown on coverslips were fixed with a 1 : 1 mixture of methanol : acetone at -20C for 10 mins. After drying, rehydrating and blocking, the co
Pictures were generously provided by Dr. David Bertwistle
Reactivity data
Product details
Anti-CDKN2A/p19ARF antibody (ab80) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Mouse samples.
What is the molecular weight of CDKN2A/p19ARF?
Anti-CDKN2A/p19ARF (ab80) specifically detects a band for CDKN2A/p19ARF (UniProt: Q64364) at a molecular weight of 17kDa.
Trusted by the scientific community
Anti-CDKN2A/p19ARF (ab80) was first used in a scientific publication in 2002 and has been cited over 220 times in peer-reviewed journals.
Reviewed by scientists
Anti-CDKN2A/p19ARF (ab80) has over 15 independent reviews from customers.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (234)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:2743 PubMed40113754
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:5360-5380 PubMed39349844
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38731817
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell reviews and reports 20:554-567 PubMed38150082
2023
Applications
Unspecified application
Species
Unspecified reactive species
Aging and disease 14:2215-2237 PubMed37199578
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 80:156 PubMed37208565
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:1221 PubMed36869047
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:3415528 PubMed36457728
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 15:4693-4708 PubMed35996686
2022
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 18:e1010628 PubMed35767594
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com